PREMIER HEALTH OF AMERICA IN (PHA.CA) Stock Overview
TSX-V:PHA - CA74052G1063 - Common Stock
PHA.CA Key Statistics, Chart & Performance
The current stock price of PHA.CA is 0.03 CAD. In the past month the price decreased by -33.33%. In the past year, price decreased by -81.25%.
PHA.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| WELL-DB.CA | WELL HEALTH TECHNOLOGIES | N/A | 25.43B | ||
| AND.CA | ANDLAUER HEALTHCARE GROUP IN | 34.17 | 2.09B | ||
| DNTL.CA | DENTALCORP HOLDINGS LTD | 19.4 | 1.56B | ||
| WELL.CA | WELL HEALTH TECHNOLOGIES COR | N/A | 1.18B | ||
| AIDX.CA | HEALWELL AI INC | N/A | 353.42M | ||
| QIPT.CA | QUIPT HOME MEDICAL CORP | N/A | 150.62M | ||
| NLH.CA | NOVA LEAP HEALTH CORP | N/A | 25.76M | ||
| NPTH.CA | NEUPATH HEALTH INC | N/A | 17.51M | ||
| ARC.CA | ARCPOINT INC | 1.33 | 5.13M |
Related stock screener links
About PHA.CA
Company Profile
Premier Health of America, Inc. engages in the provision of staffing and outsourced service solutions for healthcare needs. The company is headquartered in Blainville, Quebec. The company went IPO on 2018-12-24. The firm uses its proprietary LiPHe platform to lead the healthcare services sector digital transformation to provide patients with more accessible care services. The Company’s segments include Per Diem and Travel Nurses. The Per diem segment includes Placement Premier Soin and Code Bleu, two of its Quebec subsidiaries that offer their respective services for nursing and assistance by profile and by region. Per diem nurses work on an as-needed basis, sometimes for multiple health care institutions. The Travel Nurses segment includes Canadian Health Care Agency, Solution Staffing, Premier Health Nordik, and Solutions Nursing, four of its subsidiaries that offer their respective services to the federal and provincial governments for nursing and assistance, mostly in remote regions.
Company Info
PREMIER HEALTH OF AMERICA IN
1114 Cure-Labelle Blvd., Suite 01
Blainville QUEBEC J7C 2M9 CA
CEO: Martin Legault
Employees: 20
Phone: 18002319916
PREMIER HEALTH OF AMERICA IN / PHA.CA FAQ
What is the stock price of PREMIER HEALTH OF AMERICA IN today?
The current stock price of PHA.CA is 0.03 CAD.
What is the ticker symbol for PREMIER HEALTH OF AMERICA IN stock?
The exchange symbol of PREMIER HEALTH OF AMERICA IN is PHA and it is listed on the TSX Venture Exchange exchange.
On which exchange is PHA.CA stock listed?
PHA.CA stock is listed on the TSX Venture Exchange exchange.
What is the price forecast or stock price prediction for PREMIER HEALTH OF AMERICA IN stock?
8 analysts have analysed PHA.CA and the average price target is 0.2 CAD. This implies a price increase of 580% is expected in the next year compared to the current price of 0.03. Check the PREMIER HEALTH OF AMERICA IN stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is PREMIER HEALTH OF AMERICA IN worth?
PREMIER HEALTH OF AMERICA IN (PHA.CA) has a market capitalization of 1.67M CAD. This makes PHA.CA a Nano Cap stock.
How many employees does PREMIER HEALTH OF AMERICA IN have?
PREMIER HEALTH OF AMERICA IN (PHA.CA) currently has 20 employees.
What are the support and resistance levels for PREMIER HEALTH OF AMERICA IN (PHA.CA) stock?
PREMIER HEALTH OF AMERICA IN (PHA.CA) has a resistance level at 0.04. Check the full technical report for a detailed analysis of PHA.CA support and resistance levels.
Is PREMIER HEALTH OF AMERICA IN (PHA.CA) expected to grow?
The Revenue of PREMIER HEALTH OF AMERICA IN (PHA.CA) is expected to decline by -20.72% in the next year. Check the estimates tab for more information on the PHA.CA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy PREMIER HEALTH OF AMERICA IN (PHA.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of PHA.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of PHA.CA, evaluating the profitability, health, valuation and growth aspects
- PREMIER HEALTH OF AMERICA IN (PHA.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- PREMIER HEALTH OF AMERICA IN (PHA.CA) Sales and EPS estimates to see what analysts future expectations are.
- PREMIER HEALTH OF AMERICA IN (PHA.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- PREMIER HEALTH OF AMERICA IN (PHA.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- PREMIER HEALTH OF AMERICA IN (PHA.CA) Stock Chart to make your own analysis
- PREMIER HEALTH OF AMERICA IN (PHA.CA) Latest news and press-releases to stay up to date.
Does PREMIER HEALTH OF AMERICA IN (PHA.CA) stock pay dividends?
PHA.CA does not pay a dividend.
When does PREMIER HEALTH OF AMERICA IN (PHA.CA) report earnings?
PREMIER HEALTH OF AMERICA IN (PHA.CA) will report earnings on 2025-12-08.
What is the Price/Earnings (PE) ratio of PREMIER HEALTH OF AMERICA IN (PHA.CA)?
PREMIER HEALTH OF AMERICA IN (PHA.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.29).
PHA.CA Technical Analysis
PHA.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to PHA.CA. PHA.CA has a bad profitability rating. Also its financial health evaluation is rather negative.
PHA.CA Financial Highlights
Over the last trailing twelve months PHA.CA reported a non-GAAP Earnings per Share(EPS) of -0.29. The EPS decreased by -410.9% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -25.76% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
PHA.CA Forecast & Estimates
8 analysts have analysed PHA.CA and the average price target is 0.2 CAD. This implies a price increase of 580% is expected in the next year compared to the current price of 0.03.
For the next year, analysts expect an EPS growth of 40.21% and a revenue growth -20.72% for PHA.CA